Pine Labs' valuations are a discount to peers and can re-rate with consistent growth, the Jefferies report stated, with the brokerage projecting a 29% upside potential for the stock.Pine Labs' valuations are a discount to peers and can re-rate with consistent growth, the Jefferies report stated, with the brokerage projecting a 29% upside potential for the stock.
Pine Labs shares get their first 'buy' rating after listing; Jefferies sees the stock touching ₹300
API Publisher